Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

462
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
462
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
The Tumor Microenvironment02:17

The Tumor Microenvironment

7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Survival Analysis01:21

Cancer Survival Analysis

650
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
650
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

3.7K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypovitaminosis D in acute inpatient cancer rehabilitation: Prevalence, predictors, and practical implications.

PM & R : the journal of injury, function, and rehabilitation·2026
Same author

A Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology Clinical Practice Statement: Management of social eating and drinking challenges in adults with cancer.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Peripheral Edema in Advanced Cancer: Mechanisms and Management-A Scoping Review.

Journal of palliative medicine·2026
Same author

Perception Toward Take Home Naloxone Among Patients With Cancer on Opioids Who Live Alone.

Journal of pain and symptom management·2026
Same author

The Role of New Agents and Supportive Care in a Multimodal Approach to Cancer Cachexia.

Cancers·2026
Same author

Nutrition rehabilitation programs and cachexia clinics for anorexia-cachexia syndrome in patients with cancer.

The oncologist·2026

Related Experiment Video

Updated: Jan 18, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K

Endocrinopathies and cancer cachexia.

Rony Dev1, Egidio Del Fabbro2, Shalini Dalal1

  • 1Symptom Control & Palliative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.

Current Opinion in Supportive and Palliative Care
|October 1, 2019
PubMed
Summary

Cancer cachexia, characterized by muscle and fat loss, requires addressing metabolic issues like insulin resistance and hormonal imbalances. Future treatments may target these underlying causes to combat weight loss in cancer patients.

More Related Videos

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.6K
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

1.2K

Related Experiment Videos

Last Updated: Jan 18, 2026

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
08:55

The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia

Published on: November 30, 2016

17.1K
Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model
06:32

Intra-Cardiac Injection of Human Prostate Cancer Cells to Create a Bone Metastasis Xenograft Mouse Model

Published on: November 4, 2022

6.6K
Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
07:20

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy

Published on: January 31, 2025

1.2K

Area of Science:

  • Endocrinology
  • Metabolic Syndrome
  • Oncology

Background:

  • Cancer cachexia is a complex condition involving muscle and fat loss, leading to poor outcomes.
  • It is driven by factors including reduced food intake, inflammation, and metabolic changes.
  • Current treatments offer limited success in reversing weight loss and improving patient status.

Purpose of the Study:

  • To review the role of endocrine abnormalities in cancer cachexia.
  • To highlight potential therapeutic interventions targeting metabolic derangements.
  • To focus on insulin resistance, ghrelin signaling, and hypogonadism.

Main Methods:

  • Literature review of endocrine and metabolic factors in cancer cachexia.
  • Analysis of current research on therapeutic targets.
  • Synthesis of findings on insulin resistance, ghrelin, and hypogonadism.

Main Results:

  • Endocrine abnormalities, including insulin resistance and hypogonadism, contribute significantly to cancer cachexia.
  • Altered ghrelin signaling impacts appetite and metabolism.
  • These factors exacerbate weight loss and muscle mass reduction.

Conclusions:

  • Standard nutritional support is insufficient for reversing cancer cachexia.
  • Targeting insulin resistance, ghrelin signaling, and hypogonadism offers promising therapeutic avenues.
  • Future interventions may improve body composition and combat cancer cachexia.